Eicosanoids are known to be involved in inflammation and insulin sensitivity72, suggesting dysregulation of PLA2s may increase insulin resistance and related metabolic disorders via disruption of eicosanoid signaling. This evidence concerns the gene PLA2G2A and Other metabolic disease.